Latest filing published 06 Sept 2021 for Strides Pharma Science Limited, €13k.
Filing timeline
BuySaleAmit Gupta: trading record in brief
Amit Gupta, listed as chief executive, appears in our data through filings on Strides Pharma Science Limited shares, published by SEBI (PIT + SAST). We count 2 filings; the first trade dates from 30 June 2021 and the latest from 6 September 2021.
The open-market record consists of 1 sale worth €32k, with no purchase. Outside the open market, there are 1 share grant.
Most recently, on 6 September 2021, the filings show a share grant worth €13k in Strides Pharma Science Limited. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEBI (PIT + SAST). They describe what insiders did and are not a recommendation.
Companies and markets linked to Amit Gupta
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 3,750 shares@ ₹301.000.0000% mcap28.8% of flowEquity SharesSEBI:43a75685095cb6fe8f5dc243b3c1243dacf97450Canonical exit: 5 Dec 2021 (T+90)
- 3,750 shares@ ₹757.33090.0001% mcap71.2% of flowEquity SharesSEBI:c44a5a569cc57282acbe3344cbfadbeb8b3ef8ba
2 of 2 declarations